TRDA - Financial Reports List - Entrada Therapeutics, Inc. - IntrinsicAlpha

Entrada Therapeutics, Inc. TRDA

Healthcare - Biotechnology - NASDAQ - US

$ 8.19

3.15 %

$ 308 M

Market Cap

4.88

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	-10.63%	111.85%	-119.61%
Annual Report	FY	10-K	2024-12-31	63.38%	1081.69%	1586.75%
Quarterly Report	Q3	8-K	2024-09-30	-55.25%	-39.57%	-154.57%
Quarterly Report	Q2	8-K	2024-06-30	421.16%	312.25%	427.77%
Quarterly Report	Q1	8-K	2024-03-31	134.05%	452.05%	1497.05%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	57.02%	119.18%
Annual Report	FY	10-K	2023-12-31	0.00%	92.36%	96.75%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	250.65%	154.03%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-15.89%	30.88%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	67.78%	105.97%

1